To grow, Indian pharma must embrace innovation, technology

03/13/2013 | PharmaTimes (U.K.)

Indian drug companies must focus on new technologies, including development of "super-generics," in order to grow and flourish, said Andrew Barrett, director of medical technology in India at Cambridge Consultants. "[T]he required investments can be recouped because medical products have long lifecycles," he added. Other experts at a Mumbai conference noted that the biggest growth opportunities will come from innovations to differentiate products, because the number of expiring drug patents has peaked, and other countries are offering greater competition for low-cost generics.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA